TrialThe Journal of infectious diseases2016

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

Anna P Durbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.